{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T07:52:25Z","timestamp":1721029945627},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/inf.0000000000000569","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T11:31:11Z","timestamp":1411471871000},"page":"433-434","source":"Crossref","is-referenced-by-count":4,"title":["Presentation of Severe Combined Immunodeficiency with Respiratory Syncytial Virus and Pneumocystis Co-infection"],"prefix":"10.1097","volume":"34","author":[{"given":"Nerea","family":"Dom\u00ednguez-Pinilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Allende-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Corral S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"de Inocencio Arocena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Ignacio","family":"Gonz\u00e1lez-Granado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory syncytial virus: a comprehensive review.","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"R2-19-20210202","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1258\/095646207779949583","article-title":"Multi-skeletal Pneumocystis jiroveci (carinii) in an HIV-seropositive patient.","volume":"18","author":"Panos","year":"2007","journal-title":"Int J STD AIDS"},{"key":"R3-19-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08830185.2011.644607","article-title":"Severe combined immunodeficiencies: new and old scenarios.","volume":"31","author":"Aloj","year":"2012","journal-title":"Int Rev Immunol"},{"key":"R4-19-20210202","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1007\/s10875-013-9952-8","article-title":"Severe combined immunodeficiency (SCID) in Canadian children: a national surveillance study.","volume":"33","author":"Rozmus","year":"2013","journal-title":"J Clin Immunol"},{"key":"R5-19-20210202","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2013.07.052","article-title":"Primary Immune Deficiency Treatment Consortium (PIDTC) Report.","volume":"133","author":"Griffith","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"R6-19-20210202","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s40265-014-0223-7","article-title":"Gene therapy for primary immunodeficiencies: current status and future prospects.","volume":"74","author":"Qasim","year":"2014","journal-title":"Drugs"},{"key":"R8-19-20210202","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.all.0000191889.35516.b6","article-title":"Cytokine-mediated signalling and early defects in lymphoid development.","volume":"5","author":"Giliani","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R9-19-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1542\/peds.2007-1102","article-title":"Risk factors for severe respiratory syncytial virus disease in children with cancer: the importance of lymphopenia and young age.","volume":"121","author":"El Saleeby","year":"2008","journal-title":"Pediatrics"},{"key":"R10-19-20210202","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/jac\/dkt111","article-title":"Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections.","volume":"68","author":"Shah","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"R11-19-20210202","doi-asserted-by":"crossref","first-page":"e1695","DOI":"10.1542\/peds.2011-1768","article-title":"The use of intravenous palivizumab for treatment of persistent RSV infection in children with leukemia.","volume":"130","author":"Santos","year":"2012","journal-title":"Pediatrics"},{"key":"R12-19-20210202","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e3181343b7e","article-title":"Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.","volume":"26","author":"Chavez-Bueno","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R13-19-20210202","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1702228","article-title":"Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin.","volume":"25","author":"Ghosh","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"R14-19-20210202","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/bmt.2013.112","article-title":"Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation.","volume":"48","author":"Casey","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R15-19-20210202","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.healun.2012.04.002","article-title":"Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation.","volume":"31","author":"Li","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"R16-19-20210202","first-page":"503","article-title":"Splenic pneumocystosis: an atypical presentation of extrapulmonary Pneumocystis infection.","volume":"18","author":"ONeal","year":"2008","journal-title":"AIDS Read"},{"key":"R17-19-20210202","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07438.x","article-title":"Bone marrow involvement by Pneumocystis jiroveci.","volume":"145","author":"Grier","year":"2009","journal-title":"Br J Haematol"},{"key":"R18-19-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/INF.0b013e31822db772","article-title":"Outcomes and duration of Pneumocystis jiroveci pneumonia therapy in infants with severe combined immunodeficiency.","volume":"31","author":"Lundgren","year":"2012","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:05:49Z","timestamp":1620954349000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201504000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000569","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}